Sensitive

Alzheimer's disease (late onset)

APOE · rs2075650

Share:

Where this position leads

Condition: Alzheimer's Disease Risk (APOE)

Drug: Lecanemab and other anti-amyloid antibodies

rs2075650 Condition: Alzheimer's Disease Risk (APOE) Alzheimer's Disease Risk (APOE) Condition Drug: Lecanemab and other anti-amyloid antibodies Lecanemab and other anti-amyloid antibodies Drug rs2075650 APOE

What each result means

A/A Published research associates this genotype with typical/baseline likelihood of Alzheimer's disease (late onset) — no copies of the reported risk allele. (GWAS Catalog, PLoS Genet 2010, PMID:20885792)
A/G Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with Alzheimer's disease (late onset). (GWAS Catalog, PLoS Genet 2010, PMID:20885792)
G/G Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Alzheimer's disease (late onset) compared to the general population. (GWAS Catalog, PLoS Genet 2010, PMID:20885792)

Source: GWAS Catalog, PLoS Genet 2010, PMID:20885792

Share:

← See all variants